Frank Rimerman Advisors LLC Takes Position in Encompass Health Corporation $EHC

Frank Rimerman Advisors LLC acquired a new position in Encompass Health Corporation (NYSE:EHC) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,710 shares of the company’s stock, valued at approximately $210,000.

Several other large investors have also recently bought and sold shares of EHC. Pinnacle Wealth Planning Services Inc. increased its holdings in shares of Encompass Health by 4.0% during the 1st quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company’s stock worth $263,000 after purchasing an additional 99 shares during the period. Securian Asset Management Inc. increased its stake in Encompass Health by 1.3% during the second quarter. Securian Asset Management Inc. now owns 7,716 shares of the company’s stock valued at $946,000 after acquiring an additional 100 shares during the period. State of Michigan Retirement System raised its holdings in Encompass Health by 0.4% in the 2nd quarter. State of Michigan Retirement System now owns 24,245 shares of the company’s stock valued at $2,973,000 after acquiring an additional 100 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its holdings in Encompass Health by 19.0% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock valued at $73,000 after acquiring an additional 115 shares in the last quarter. Finally, UMB Bank n.a. lifted its position in shares of Encompass Health by 10.9% in the 2nd quarter. UMB Bank n.a. now owns 1,187 shares of the company’s stock worth $146,000 after acquiring an additional 117 shares during the period. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Stock Up 1.5%

Shares of NYSE:EHC opened at $114.44 on Friday. Encompass Health Corporation has a 52 week low of $87.85 and a 52 week high of $127.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The company’s fifty day moving average is $121.34 and its 200-day moving average is $119.54. The company has a market capitalization of $11.51 billion, a PE ratio of 21.63, a P/E/G ratio of 2.20 and a beta of 0.91.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. The business had revenue of $136.30 million during the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Equities research analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be issued a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Friday, January 2nd. Encompass Health’s payout ratio is presently 14.37%.

Wall Street Analyst Weigh In

A number of brokerages recently commented on EHC. Wall Street Zen lowered Encompass Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Bank of America boosted their price target on shares of Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a report on Wednesday, September 10th. KeyCorp raised their price objective on shares of Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Tuesday, September 16th. Barclays lifted their target price on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research report on Thursday, October 30th. Finally, Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, Encompass Health presently has an average rating of “Buy” and an average target price of $142.86.

Insider Buying and Selling

In related news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the sale, the executive vice president directly owned 18,846 shares in the company, valued at $2,329,177.14. This represents a 5.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.00% of the stock is currently owned by company insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.